Condition
Cancer Cachexia Syndrome clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Cancer Cachexia Syndrome clinical trials that are recruiting, in China. By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
First-in-human test of QLS2319 in healthy adults and cancer cachexia
This study tests QLS2319 in healthy adults and people with cancer cachexia to see if it is safe, tolerated, and how it behaves in the body, with a look at early signs of benefit.
-
Single-dose GB18 injections in healthy adults (dose-escalation)
This trial will test single subcutaneous doses of GB18 versus placebo in healthy adults to see if the drug is safe, how it behaves in the body, how it affects the circulating protein GDF15, and whether it triggers immune responses.
Related topics
Quick answers
How many Cancer Cachexia Syndrome clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.